June 1, 2016

Making prostate cancer diagnosis more PRECISE

Dr. Laurence Klotz of the Sunnybrook Research Institute

Dr. Laurence Klotz of Sunnybrook Health Sciences Centre is a world leader in the field of prostate cancer research. He has been a champion of active surveillance (also known as watchful waiting) for over 20 years, an approach to prostate cancer treatment that has allowed thousands of men with low-risk prostate cancer to avoid or delay therapy by monitoring it closely instead of immediately treating it.

Now Klotz has launched a new clinical trial called PRECISE, funded with $3 million in support by the Movember Foundation, the Ontario Institute for Cancer Research and Prostate Cancer Canada, that will use MRI to help to better diagnose prostate cancer without invasive biopsy.

Continue reading – Making prostate cancer diagnosis more PRECISE

May 13, 2016

OICR researcher receives $2 million in federal funding to study metabolic conditions that can lead to cancer

The OHS Team

Dr. Philip Awadalla and the Ontario Health Study team.

Chronic health conditions place a heavy burden on patients and their families, and cost the healthcare system and the Canadian economy staggering amounts. Chronic diseases were behind 67 per cent of total direct costs in health care and 60 per cent of total indirect costs as a result of early death, loss of productivity and foregone income, according to a 2006 study by the Public Health Agency of Canada. Globally, non-communicable disease (NCD) was made a priority by the World Health Organization, leading to the formation of the NCD Alliance and the Sharjah Declaration, which aims to reduce the global burden of NCDs.

Continue reading – OICR researcher receives $2 million in federal funding to study metabolic conditions that can lead to cancer

May 2, 2016

$2 million in new funding from Canadian Institutes of Health Research will help Ontario team study metabolic syndromes

Dr. Philip Awadalla

Dr. Philip Awadalla

Toronto (May 2, 2016) – Dr. Philip Awadalla, Senior Investigator at the Ontario Institute for Cancer Research and Principal Investigator for the Ontario Health Study has been awarded $2 million by the Canadian Institutes of Health Research (CIHR).  The award will fund the study of the role of both genes and the environment on the development of metabolic syndrome, a cluster of medical conditions that are common in aging adults, including obesity, hypertension, high cholesterol, high blood sugar and insulin resistance.

These conditions are considered to be both risk factors and causal factors in the development of cancer and chronic diseases like heart disease, stroke and diabetes. A better understanding of how to prevent and treat the conditions of metabolic syndrome could also help in the design of new strategies to prevent these diseases before they develop.

Continue reading – $2 million in new funding from Canadian Institutes of Health Research will help Ontario team study metabolic syndromes